Rite Aid Stock Today

<div class='circular--portrait' style='background:#FF6600;color: #FFFAFA;font-size:4em;padding-top: 25px;;'>RA</div>
Rite Aid is trading at 18.12 as of the 2nd of July 2020, which is 4.80 percent up since the beginning of the trading day. The stock's lowest day price was 17.47. Rite Aid has about a 38 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 30 trading days. Equity ratings for Rite Aid are calculated daily based on the scoring framework. The performance scores are derived for the period starting the 3rd of April 2020 and ending today, the 2nd of July 2020. Click here to learn more.
Analyze Filter   Fiscal Quarter End: 31st of August 2020

   Performance
8 100 

   Odds of Distress
38  

Rite Aid Profile

Next fiscal quarter end is expected on the 31st of August 2020. Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. Rite Aid Corporation was founded in 1962 and is headquartered in Camp Hill, Pennsylvania. Rite Aid operates under Pharmaceutical Retailers classification in the United States and is traded on BATS Exchange. It employs 29840 people. more on Rite Aid
Legal NameRite Aid
CEOHeyward DoniganView All
Average Analyst Recommendation
Current trade recommendation based on an ongoing consensus estimate among financial analysis covering Rite Aid. The Rite Aid consensus assessment is calculated by taking the average estimates from all of the analysts covering Rite Aid
Piotroski F Score
Academic score (developed by Joseph Piotroski in 2002) to determine the current strength of Rite Aid financial position. Scores of 8 and 9 are usually clasified strong value stocks whereas scores of 2 or below are considered weak value stocks.
 7 - StrongDetails
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares48.4 M53.2 M
Significantly Down
Increasing
Slightly volatile
Weighted Average Shares Diluted48.7 M53.2 M
Significantly Down
Increasing
Slightly volatile
Net Cash Flow from Operations444.5 M510.9 M
Fairly Down
Decreasing
Slightly volatile
Total Assets8.6 B9.5 B
Significantly Down
Increasing
Slightly volatile
Total Liabilities9.9 B8.8 B
Moderately Up
Decreasing
Stable
Current Assets4.5 B3.7 B
Fairly Up
Decreasing
Stable
Current Liabilities2.6 B2.8 B
Significantly Down
Increasing
Stable
Total Debt4.8 BB
Sufficiently Down
Decreasing
Very volatile
Return on Average Assets(5.4457)(5.306)
Fairly Down
Decreasing
Slightly volatile
Gross Margin26.0721.5554
Fairly Up
Decreasing
Slightly volatile
Asset Turnover3.112.5803
Fairly Up
Decreasing
Slightly volatile
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Rite Aid available fundamental, technical, and predictive indicators. Current horizon is 30 days (very short) - details
Strong SellOvervalued
Financial Strength
Rite Aid financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Rite Aid success along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
B- ( Average Bond Rating ) Extremely Weak
  Operating Cash Flow
Rite Aid (RAD) is traded on BATS Exchange in USA and employs 29,840 people. The company currently falls under 'Small-Cap' category with total capitalization of 769.89 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Rite Aid's market, we take the total number of its shares issued and multiply it by Rite Aid's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Rite Aid runs under Healthcare sector within Pharmaceutical Retailers industry. The entity has 54.87 M outstanding shares of which 14.06 M shares are at this time shorted by investors with about 4.66 days to cover shorted positions. RITE AID CP has about 149.12 M in cash with (198.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.95.
Check Rite Aid Probability Of Bankruptcy

Ownership Allocation (%)

Rite Aid Stock Price Odds Analysis

Odds Down 18.12HorizonTargetOdds Up 18.12
99.99%30 days
 18.12 
0.01%
Based on a normal probability distribution, the odds of Rite Aid to move above the current price in 30 days from now is near 1 (This Rite Aid probability density function shows the probability of Rite Aid Stock to fall within a particular range of prices over 30 days) .

Rite Aid Stock Institutional Holders

InstituionSecurity TypeTotal SharesValue
Vanguard Group IncCommon Shares5.3 M79 M
Blackrock IncCommon Shares4.4 M65.4 M
Susquehanna International Group LlpPut Options1.5 M22 M
Simplex Trading LlcCall Options13.1 K19.7 M
View Rite Aid Diagnostics

Rite Aid Income Statement Over Time

Rite Aid Income Statement is one of the three primary financial statements used for reporting Rite Aid's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Rite Aid revenue and expense. Rite Aid Income Statement primarily focuses on the company's revenues and expenses during a particular period. Rite Aid Consolidated Income is expected to increase significantly based on the last few years of reporting. The past year's Consolidated Income was at 1.9 Billion. The current year Earning Before Interest and Taxes EBIT is expected to grow to about 800.6 M, whereas Gross Profit is expected to decline to about 6.1 B. View More Fundamentals

Rite Aid Stock Against Markets

Did you try this?

Run Fund Screener Now

   

Fund Screener

Find activelly-traded funds from around the world traded on over 30 global exchanges
All  Next Launch Module

Rite Aid Upcoming and Recent Events

Rite Aid Company Earnings Announcements Dates

Upcoming Quarterly Report24th of September 2020
Next Earnings Report17th of December 2020
Next Fiscal Quarter End31st of August 2020
Next Fiscal Year End15th of April 2021
Last Quarter Report31st of May 2020
Last Earning Anouncement31st of August 2019

Rite Aid Corporate Directors

Joseph Anderson Independent Director
Elizabeth Burr Independent Director
Michael Regan Lead Independent Director
Additionally, take a look at Your Equity Center. Please also try Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Company logos by clearbit
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page